Richard A. Morgan - Concepedia

Author

Richard A. Morgan

Also Known As

Alan Ashworth, Ang Li, Christopher L. Wolfgang, R A Morgan, R Morgan, RICHARD A. MORGAN, Richard A Morgan, Richard A. Morgan, Richard D. Morgan, Richard Morgan

253

Publications

34.5K

Citations

H-Index

118

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Human Genome Research Institute Johns Hopkins University

About

Richard A. Morgan is an author at National Cancer Institute specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	40	12.2K
2	Health Sciences	4	4	407
3	Education	1	1	24
4	Engineering	1	1	24
5	Natural Sciences	1	1	17

Richard A. Morgan

Publications

29.6K

Citations

H-Index

Page 1

	Year	Citations
Genomic analyses identify molecular subtypes of pancreatic cancer Peter J. Bailey, David K. Chang, Kátia Nones, Nature Pancreatic CancerMedicinePathologyCancer GenomicsMolecular Diagnostics	2016	3.6K
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Science Lymphoid NeoplasiaCell TherapyCancer ImmunosurveillanceMedicineCancer Regression	2006	2.6K
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 Richard A. Morgan, James C. Yang, Mio Kitano, Molecular Therapy	2010	2.5K
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Dmitri Nepogodiev, Aneel Bhangu, James Glasbey, The Lancet International Cohort StudyMedicinePatient SafetyPerioperative SafetyPost-operative Care	2020	1.7K
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma Noopur Raje, Jesús G. Berdeja, Yi Lin, New England Journal of Medicine	2019	1.7K
T Lymphocyte-Directed Gene Therapy for ADA <sup>−</sup> SCID: Initial Trial Results After 4 Years R. Michael Blaese, Kenneth W. Culver, A. Dusty Miller, Science	1995	1.5K
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman, Blood	2011	1.4K
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Blood	2010	1.3K
Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction Steven A. Rosenberg, Paul Aebersold, Kenneth Cornetta, New England Journal of Medicine	1990	1.3K
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems Natasha J. Caplen, Susan Parrish, Farhad Imani, Proceedings of the National Academy of Sciences	2001	1K

Page 1